newsfilter
← Latest News
PR Newswire·

Positive top-line results from the phase 3 PRINCE study of pegcetacoplan in treatment-naïve patients with PNH

STOCKHOLM, May 25, 2021 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) and Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) (GLOBE NEWSWIRE) today reported positive top-line results from the phase 3 PRINCE study evaluating the efficacy and safet